TRD
Articles tagged with “TRD”
Glutamate Pathway Treatments Reshape TRD Care in 2026
New research highlights glutamate-targeting treatments for TRD, including esketamine and ketamine troches. Here's what it means for your care plan.
Esketamine vs. Troches: What TRD Patients Should Know
A new clinical review on esketamine for TRD highlights access barriers and patient preferences — here's what it means for ketamine troche therapy.
Esketamine TRD Access Gaps Open Doors for Troches
New clinician data on esketamine for TRD reveals access barriers that make compounded ketamine troches a practical frontline option for many patients.
Glutamate Pathways Are Reshaping TRD Treatment
A 2026 review highlights how glutamate-targeting drugs like esketamine and ketamine troches are redefining treatment-resistant depression care.
Ketamine Troches for Depression: Evidence and Protocols
Ketamine troches show significant promise for treatment-resistant depression. Review the clinical evidence, mechanisms of action, treatment protocols, and what to expect from troche-based antidepressant therapy.
Using Ketamine Troches for Maintenance vs. Acute Treatment
Ketamine troches serve different roles in acute and maintenance treatment. Learn about loading protocols, maintenance frequency, response durability, and when to reassess your treatment phase.
Contact Ketamine Troche
Send corrections, provider questions, or advertising inquiries.